Leg pain on Wegovy: deciding what it means and what to do next

Leg pain is not a recognised common side effect of semaglutide in the Wegovy clinical trial programme — most cases have an alternative explanation.
Rapid weight loss can put changed demands on muscles, tendons and joints, which may produce aching legs during treatment, particularly in the first few months.
Semaglutide slows gastric emptying, which can reduce absorption of oral medicines; if you take anything that affects leg circulation or muscle function, your prescriber should know.
Severe, sudden or one-sided leg pain with swelling or skin changes needs urgent medical assessment, do not wait for your next scheduled review.

Leg pain reported alongside Wegovy (semaglutide) is not listed as a common side effect in the medicine's clinical trials, but people do notice it — and the reason usually matters more than the symptom itself. Before assuming the injection is the cause, it's worth working through a short list of more likely explanations, because most turn out to be unrelated to semaglutide. These are prescription-only medicines, and any new or persistent pain in your legs should be discussed with a clinician who knows your full picture.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Working through the likely causes, and knowing when to act fast

Why Wegovy probably isn't the direct cause of your leg pain

The first thing worth saying clearly: the phase 3 STEP trials, which enrolled thousands of adults over 68 weeks, did not flag leg pain as a common adverse effect of semaglutide 2.4mg. The NHS patient information for semaglutide lists the side effects most frequently reported in trials, and they are dominated by gastrointestinal symptoms such as nausea, diarrhoea and constipation. You can read that list in full on the NHS semaglutide medicines page.

That doesn't mean leg discomfort can't happen while taking Wegovy. It means the medicine itself is rarely the direct mechanism. A common misconception is that any symptom appearing after starting an injection must be caused by it, the timing feels compelling, but correlation isn't causation, and this one is worth letting go of gently before you stop a treatment that may be genuinely helping you.

The more productive question is: what else has changed? Weight, activity levels, hydration and diet all shift during treatment, and those changes carry their own physical effects. Our Wegovy overview covers what the treatment actually does in the body, which can help you separate its known effects from coincidental ones.

Three plausible explanations worth considering first

Rapid or sustained weight loss changes the mechanical load on your lower limbs in ways that can produce muscle soreness, tendon sensitivity or joint aching, particularly if you have also increased activity during treatment, as most clinical guidance encourages. Legs that are carrying less weight still need time for muscles, tendons and fascia to adjust to the new dynamic.

Reduced caloric intake can sometimes lead to lower potassium, magnesium or sodium levels, particularly if nausea and vomiting have made eating difficult. Electrolyte imbalances are a known cause of muscle cramps and leg aching, and they're easy to miss if you're attributing every symptom to the injection. If you've also experienced significant nausea or vomiting, the stomach pain and Wegovy resource covers how GI symptoms can have downstream effects on how the rest of the body feels.

Reduced physical activity (or a sudden increase in it) can both produce leg pain in their own way. Deconditioning during weeks of appetite suppression, followed by a return to walking or exercise, can make muscles protest in ways that are perfectly normal but poorly timed.

Leg pain that deserves same-day attention

There are patterns of leg pain that need urgent assessment regardless of what medicine you're taking. Sudden, severe pain in one leg (especially paired with swelling, warmth, redness or skin that feels tight) raises the possibility of deep vein thrombosis (DVT). This is not a Wegovy-specific risk, but it is serious. Similarly, pain in the calf that worsens when walking and eases at rest can point to circulatory causes that need a clinician to assess promptly.

If you experience any of those features, call NHS 111 or go to your nearest urgent treatment centre. Don't wait for your next scheduled review. The NHS semaglutide guidance is clear that unexpected or severe symptoms should always be assessed by a healthcare professional without delay. You can also explore some of the related physical discomforts people report on Wegovy (including back pain and injection-site skin reactions) which sometimes get grouped together with leg discomfort but have quite distinct causes.

Deciding whether to continue treatment and who makes that call

This is the decision the SK3 framing is built for: should you stop, continue, or seek review? For the vast majority of people experiencing mild, bilateral leg aching that arrived alongside weight loss or increased walking, the answer is to continue and monitor, whilst mentioning it at the next clinical check-in. Stopping a prescription medicine without clinical input is rarely the right move when the symptom has no red-flag features.

For anything that feels unusual, one-sided, severe or that arrived alongside other new symptoms, you need a prescriber involved before making any changes. If you're using Wegovy through a private service like ours, the aftercare team is the right first contact, not a forum, not a general search. Our frequently asked questions cover how aftercare works and what to do if you have a concern between doses.

Semaglutide also slows gastric emptying, which can affect how other oral medicines are absorbed. If you take anything for blood pressure, circulation or muscle conditions alongside Wegovy, it's worth telling your prescriber, especially if leg symptoms appeared after a dose increase. For context on how semaglutide works mechanically, that page goes into more detail on gastric emptying and drug interactions. And if you're thinking about what your ongoing treatment should look like (including cost and what's included) the Wegovy pricing page sets out what a private prescription covers. When you're ready to speak to a prescriber about your symptoms or your next step, you can check your eligibility through a free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions